AstraZeneca

AstraZeneca

AstraZenecaAstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. For more information visit www.astrazeneca.com.

AstraZeneca RSS Channel

Filters
List of articles in category AstraZeneca
Title Published Date
BRILIQUE receives a positive preliminary medical benefit assessment 04 October 2011
Additional Analyses from PLATO Presented at ESC Congress 29 August 2011
Positive agreement received for approval of AXANUM in Europe 02 August 2011
AstraZeneca extends its investment in Russia with new predictive science centre in St Petersburg 16 June 2011
AstraZeneca and Heptares collaborate to investigate important GPCR drug targets 31 May 2011
Health economics substudy of PLATO shows BRILIQUE to be a cost effective treatment 09 May 2011
European Commission approves nasal spray vaccine FLUENZ 01 February 2011
AstraZeneca and Abbott end license agreement for the development of Certriad 22 December 2010
European Commission Approves Brilique™ (Ticagrelor Tablets) 06 December 2010
Positive agreement received for approval of VIMOVO in Europe 11 October 2010
BRILIQUE (ticagrelor) receives positive opinion from European CHMP for the treatment of Acute Coronary Syndromes 24 September 2010
European Commission Issues Positive Decision for Approval of Seroquel XR 03 September 2010
Genetic substudy shows fewer major cardiovascular events with ticagrelor (BRILINTA) 30 August 2010
AstraZeneca and MRC Technology Form Strategic Alliance in Discovery Research 06 July 2010
AstraZeneca Submits Marketing Authorisation Application To European Union For Cardiovascular Drug Axanum 07 June 2010
Seroquel XR Recommended For Approval In EU as an Add-On Treatment Of Major Depressive Disorder 26 April 2010
AstraZeneca Fourth Quarter and Full Year Results 2009 03 February 2010
AstraZeneca to Acquire Infection Research Company Novexel 02 January 2010
AstraZeneca PLC Third Quarter & Nine Months Results 2009 02 November 2009
AstraZeneca withdraws regulatory submissions for Zactima (vandetanib) 29 October 2009